Of the eleven scientists just announced as winners of the new Life Sciences Breakthrough Prize, four of them have their labs within a block or two of each other in Manhattan: two at Rockefeller University, one at Weill Cornell Medical College, and one at Memorial Sloan-Kettering Cancer Center. The prize, given to recognize past achievement in research aimed at curing disease and extending human life, comes with $3M to allow each of those researchers the freedom and flexibility to pursue even more groundbreaking work in the future. The founding sponsors of the prize are tech entrepreneurs Sergey Brin (Google) and Anne Wojcicki, Mark Zuckerberg (Facebook) and Priscilla Chan, Art Levinson (Apple), and Yuri Milner (venture capitalist). The 11 winners this year will serve on the board to choose 5 winners each in subsequent years.
Science Market Update
Tags: Rockefeller University, cancer research, New York, women in science, New York City, Northeast, Cancer Center, NY, Weill Cornell, BioResearch Product Faire Event, Rockefeller, Memorial Sloan-Kettering Cancer Center, 2013, 2014, RockU
Cancer research is hot, and the best in the field are hotly-courted by top cancer research centers, often with very attractive compensation packages in addition to state-of-the-art labs and equipment. As if fighting cancer weren't challenging enough, even renowned universities with world-class biomedical programs like the University of California San Diego have had some of their shining stars in the laboratory snatched away by big-money states like Texas in recent years. Not to be outdone or undermined, UCSD has recently engaged in some aggressive recruiting of its own and is proud to announce that two very important players in the cancer research field have joined the Moores Cancer Center faculty: Dr. Napoleone Ferrara (formerly of Genentech) and Dr. Razelle Kurzrock (formerly of MD Anderson at the University of Texas).
The University of Hawaii Cancer Center has successfully renewed its National Cancer Institute (NCI) designation and is on schedule to open its new world-class cancer research and treatment facility near the John A. Burns School of Medicine (JABSOM) in the Kaka’ako district of Honolulu early next year. The Hawaiian biomedical research center is the only NCI-level facility in the Pacific Islands and one of only 66 NCI research organizations in the U.S. The island state may be a tropical paradise and vacation destination in the popular imagination, but there's no doubt that its capital city is also becoming a serious biomedical research magnet as well.
Tags: cancer research, New research facilities, Southwest, biomedical research, new construction, new science wet labs, Biomedical expansion, Bioresearch, Hawaii, Cancer Center, Cancer, Honolulu, 2012, Front Line event, University of Hawaii, HI
There's a reason why top university medical centers garner the prestige (and the funding) that they do: research labs + medical school + hospital = optimization of all three units, with ripe opportunities for collaboration, sharing of resources, and recruiting the best medical scientists. So there's always reason to cheer when a major university med center like Ohio State builds new facilities, whether they're clinical or research, because both will support the institution's overall mission and budget. In the case of Ohio State's new James Cancer Center and Solove Research Institute, both patients seeking treatment and scientists doing basic and applied cancer research will benefit from the state-of-the-art building that is rising on the Columbus medical campus right now, with its opening due in 2014. The complex will house the cancer center on 12 stories; the other 8 will comprise the critical care hospital, mechanical equipment and an as yet undetermined floor.
Tags: cancer research, Ohio, Midwest, biomedical research, Ohio State University, new construction, New research facilities, Biomedical Equipment, Medical Device Technology, Biomedical expansion, Cancer Center, scientific instruments
There's been a lot of news coming out of Chicago this week from the annual meeting of the American Association for Cancer Research (AACR). Two announcements concerning prostate cancer research are especially worth broadcasting. An Ann Arbor pathologist, Arul M. Chinnaiyan, of the University of Michigan Comprehensive Cancer Center, will be leading a "dream team" of specialists from 5 of the top cancer research institutes in the world in a $10M, 3-year research project titled “Precision Therapy for Advanced Prostate Cancer.” The funding comes from AACR partner, Stand Up To Cancer (SU2C), and the Prostate Cancer Foundation (PCF). Heading up the team with Dr. Chinnaiyan is Dr. Charles L. Sawyers of Memorial Sloan-Kettering Cancer Center in New York.
Tags: University of Michigan, Midwest, Bioresearch, cancer research, nanotechnology, genome research, genomic medicine, 2012, Ann Arbor, BioResearch Product Faire Event, Funding, Research Funding, Conference, MI, science event, scientific conference, science current event, scientific events, UMich, Cancer Center, science research funding
The UC Davis Cancer Center was recently recognized as a "comprehensive" center by the National Cancer Institute (NCI). This is the most prestigious honor that a cancer center can receive and designates the renamed, UC Davis Comprehensive Cancer Center as one of the top cancer research institutions in the country.
Tags: Biomedical Research Funding, cancer research, California, Southwest, University of California Davis, Sacramento Campus, BRPF, biomedical sciences, UC Davis Cancer Center, Cancer Center, BioResearch Product Faire Event